BioCentury | Nov 19, 2007
Company News

Dicerna management update

...Boston, Mass. Business: Chemistry Hired: James Jenson as CEO, formerly president and CEO of Zapaq Inc....
BioCentury | Nov 15, 2007
Financial News

Dicerna raises $13 million

...end of 2009. Dicerna's CEO, James Jenson, was previously president and CEO of neurology company Zapaq...
BioCentury | Aug 21, 2006
Company News

Athenagen, Zapaq deal

...with Zapaq (see BioCentury, July 10 & 17). Athenagen Inc. , South San Francisco, Calif. Zapaq Inc....
BioCentury | Jul 17, 2006
Company News

Athenagen, Zapaq deal

...merge with Zapaq to form a company focused on Alzheimer's disease and other neurology indications. Zapaq...
...Sanderling is the lead investor in both companies. Athenagen Inc. , South San Francisco, Calif. Zapaq Inc....
BioCentury | Jul 11, 2006
Company News

Athenagen, Zapaq to merge

...Athenagen (South San Francisco, Calif.) plans to merge with Zapaq (Waltham, Mass.) to form a company...
...Waltham, Mass.) to form a company focused on Alzheimer's disease (AD) and other neurology indications. Zapaq...
BioCentury | Jul 10, 2006
Strategy

Aggregating in AD

...program. On Monday this week, the company planned to announce another deal: a merger with Zapaq Inc....
...be a difficult target because it is associated with more toxicity than beta, he said. Zapaq...
...Oct. 9, 2000). The company mimicked the conformation of the protein to design selective inhibitors. "Zapaq...
Items per page:
1 - 6 of 6
BioCentury | Nov 19, 2007
Company News

Dicerna management update

...Boston, Mass. Business: Chemistry Hired: James Jenson as CEO, formerly president and CEO of Zapaq Inc....
BioCentury | Nov 15, 2007
Financial News

Dicerna raises $13 million

...end of 2009. Dicerna's CEO, James Jenson, was previously president and CEO of neurology company Zapaq...
BioCentury | Aug 21, 2006
Company News

Athenagen, Zapaq deal

...with Zapaq (see BioCentury, July 10 & 17). Athenagen Inc. , South San Francisco, Calif. Zapaq Inc....
BioCentury | Jul 17, 2006
Company News

Athenagen, Zapaq deal

...merge with Zapaq to form a company focused on Alzheimer's disease and other neurology indications. Zapaq...
...Sanderling is the lead investor in both companies. Athenagen Inc. , South San Francisco, Calif. Zapaq Inc....
BioCentury | Jul 11, 2006
Company News

Athenagen, Zapaq to merge

...Athenagen (South San Francisco, Calif.) plans to merge with Zapaq (Waltham, Mass.) to form a company...
...Waltham, Mass.) to form a company focused on Alzheimer's disease (AD) and other neurology indications. Zapaq...
BioCentury | Jul 10, 2006
Strategy

Aggregating in AD

...program. On Monday this week, the company planned to announce another deal: a merger with Zapaq Inc....
...be a difficult target because it is associated with more toxicity than beta, he said. Zapaq...
...Oct. 9, 2000). The company mimicked the conformation of the protein to design selective inhibitors. "Zapaq...
Items per page:
1 - 6 of 6